GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orthocell Ltd (ASX:OCC) » Definitions » Ending Cash Position

Orthocell (ASX:OCC) Ending Cash Position : A$20.61 Mil (As of Jun. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Orthocell Ending Cash Position?

Orthocell's Ending Cash Position for the quarter that ended in Jun. 2024 was A$20.61 Mil.

Orthocell's quarterly Ending Cash Position declined from Jun. 2023 (A$24.82 Mil) to Dec. 2023 (A$19.62 Mil) but then increased from Dec. 2023 (A$19.62 Mil) to Jun. 2024 (A$20.61 Mil).

Orthocell's annual Ending Cash Position increased from Jun. 2022 (A$11.02 Mil) to Jun. 2023 (A$24.82 Mil) but then declined from Jun. 2023 (A$24.82 Mil) to Jun. 2024 (A$20.61 Mil).

Orthocell Ending Cash Position Historical Data

The historical data trend for Orthocell's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orthocell Ending Cash Position Chart

Orthocell Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.44 16.33 11.02 24.82 20.61

Orthocell Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.02 26.82 24.82 19.62 20.61

Orthocell Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Orthocell's Ending Cash Position for the fiscal year that ended in Jun. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=24.817+-4.203
=20.61

Orthocell's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=19.624+0.99
=20.61

Orthocell Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Orthocell's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Orthocell Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orthocell Ltd (ASX:OCC) » Definitions » Ending Cash Position
Comparable Companies
ASX:ADO ASX:DXB ASX:SPL ASX:ALA ASX:BIT ASX:PTX ASX:RCE ASX:ACW ASX:RAD ASX:AGN OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
90 South Street, Building 191, Murdoch University, Murdoch, Perth, WA, AUS, 6150
Website
https://www.orthocell.com.au
Orthocell Ltd is a regenerative medicine company. The company is engaged in the development and commercialisation of cell therapies and related technologies. Its product includes CelGro is a naturally derived collagen medical device for tissue repair and Ortho-ATI is a first-in-class cell therapy for the treatment of chronic tendon injuries.